These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14537134)

  • 1. The planning and design of a new PET radiochemistry facility.
    Jacobson MS; Hung JC; Mays TL; Mullan BP
    Mol Imaging Biol; 2002 Mar; 4(2):119-27. PubMed ID: 14537134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience with an 11 MeV self-shielded medical cyclotron on operation and radiation safety.
    Pant GS; Senthamizhchelvan S
    J Med Phys; 2007 Jul; 32(3):118-23. PubMed ID: 21157531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Construction of a Radiochemistry Laboratory and cGMP-Compliant Radiopharmacy Facility.
    Asor A; Metebi A; Smith K; Last K; Strauss E; Fan J
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional distribution of 2-deoxy-2[18F]-fluoro-D-glucose for metabolic imaging using positron emission tomography.
    Alagona P; Hart DT; Eikman EA
    Int J Card Imaging; 1994 Jun; 10(2):137-43. PubMed ID: 7963752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming an Academic Radiochemistry Facility for Positron Emission Tomography Drug cGMP Compliance.
    Zhu S; Mosessian S; Kroeger K; Sadeghi S; Slavik R; Kinloch S; Moore M; Allen-Auerbach M; Czernin J; Phelps M
    Mol Imaging Biol; 2020 Apr; 22(2):256-264. PubMed ID: 31240531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of an Isolator System for PET Drug Compounding with Sterilization and Dispensing Units].
    Waki A; Hashimoto Y; Suzuki H; Mizukawa Y; Kinoshita T; Ichihara H; Kaneko I; Iwakuma K; Kawamura K; Zhang MR; Fujibayashi Y
    Kaku Igaku; 2016; 53(1):1-7. PubMed ID: 28794340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mayo Clinic approaches to meet United States Pharmacopeia <797> requirements for facility design and environmental controls of nuclear pharmacy.
    Hung JC; Anderson MM
    J Nucl Med; 2009 Jan; 50(1):156-64. PubMed ID: 19091891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals.
    Calandrino R; del Vecchio A; Todde S; Fazio F
    Health Phys; 2007 May; 92(5 Suppl):S70-7. PubMed ID: 17440326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of diverse PET probes with limited resources: 24
    Collins J; Waldmann CM; Drake C; Slavik R; Ha NS; Sergeev M; Lazari M; Shen B; Chin FT; Moore M; Sadeghi S; Phelps ME; Murphy JM; van Dam RM
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11309-11314. PubMed ID: 29073049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility.
    Calandrino R; del Vecchio A; Savi A; Todde S; Belloli S
    Health Phys; 2009 Oct; 97(4):315-21. PubMed ID: 19741360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic Generators for the Production of Positron-Emitter Labeled Radiopharmaceuticals. Where Would PET Be Without Them?
    Satyamurthy N; Phelps ME; Barrio JR
    Clin Positron Imaging; 1999 Oct; 2(5):233-253. PubMed ID: 14516648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography: radioisotope and radiopharmaceutical production.
    Tochon-Danguy HJ; Sachinidis JI; Egan GF; Chan JG; Berlangieri SU; McKay WJ; Scott AM
    Australas Phys Eng Sci Med; 1999 Dec; 22(4):136-44. PubMed ID: 10740886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation surveillance in and around cyclotron facility.
    Kaur A; Sharma S; Mittal B
    Indian J Nucl Med; 2012 Oct; 27(4):243-5. PubMed ID: 24019654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of self-shielded cyclotron operation on small-animal PET/CT equipment installed nearby, on the floor just above.
    Kubo H; Otani T; Otsuka H; Harada M
    J Med Invest; 2014; 61(1-2):46-52. PubMed ID: 24705748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel, self-shielded modular radiosynthesis system for fully automated preparation of PET and therapeutic radiopharmaceuticals.
    Kroselj M; Socan A; Zaletel K; Dreger T; Knopp R; Gmeiner T; Kolenc Peitl P
    Nucl Med Commun; 2016 Feb; 37(2):207-14. PubMed ID: 26443981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioisotopic Purity of Sodium Pertechnetate 99mTc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications.
    Selivanova SV; Lavallée É; Senta H; Caouette L; Sader JA; van Lier EJ; Zyuzin A; van Lier JE; Guérin B; Turcotte É; Lecomte R
    J Nucl Med; 2015 Oct; 56(10):1600-8. PubMed ID: 26205300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of neutron induced radioactivity in the concrete walls of a PET cyclotron vault room with MCNPX.
    Martínez-Serrano JJ; Díez de los Ríos A
    Med Phys; 2010 Nov; 37(11):6015-21. PubMed ID: 21158313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production.
    Schopf E; Waldmann CM; Collins J; Drake C; Slavik R; van Dam RM
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18FDG synthesis and supply: a journey from existing centralized to future decentralized models.
    Uz Zaman M; Fatima N; Sajjad Z; Zaman U; Tahseen R; Zaman A
    Asian Pac J Cancer Prev; 2014; 15(23):10057-9. PubMed ID: 25556425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.